Here are what the editors at HealthDay consider to be the most important developments in Dermatology for July 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Lymphoid Neogenesis Identified in Melanoma Metastases
TUESDAY, July 31 (HealthDay News) -- Lymphoid follicles, comprising clusters of B lymphocytes and follicular dendritic cells (DCs) associated with high endothelial venules (HEVs), are found in melanoma metastases, but not in primary melanomas, according to a study published online July 31 in Cancer Research.
Energy-Saving Light Bulbs May Be Harmful to Human Skin
MONDAY, July 30 (HealthDay News) -- Energy-saving compact fluorescent light bulbs emit ultraviolet radiation and may have damaging effects on skin cells, according to a study published online July 20 in Photochemistry and Photobiology.
Prior Basal Cell Carcinoma Is Main Predictor of Future BCC
MONDAY, July 30 (HealthDay News) -- Prior basal cell carcinoma (BCC) is the greatest predictor of future incidence of BCC, according to a study published online July 19 in the Journal of Investigative Dermatology.
Short/Long-Term Analyses Deem Etanercept Safe for Psoriasis
FRIDAY, July 27 (HealthDay News) -- Etanercept treatment is well tolerated for psoriasis, with no indication of dose-related or cumulative toxicity in short- or long-term analyses, according to a study published in the August issue of the Journal of the American Academy of Dermatology.
Study Highlights Importance of 'Good' Skin Bacteria in Immunity
FRIDAY, July 27 (HealthDay News) -- Similar to the gut, commensal bacteria in the skin are important for protective T cell-based immunity, according to a study published online July 26 in Science.
MRSA Skin Infections Up, Linked to Furunculosis
FRIDAY, July 27 (HealthDay News) -- The incidence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in the United States is increasing and is associated with follicular infection, most commonly folliculitis followed by furunculosis, according to a review published online July 16 in the British Journal of Dermatology.
Stability of Fragrance Patch Test Preparations Examined
THURSDAY, July 26 (HealthDay News) -- Concentrations of several fragrance allergens applied to test chambers well in advance of patient testing may be reduced by 20 percent or more within hours when stored at room temperature, according to a study published online July 14 in the British Journal of Dermatology.
Immunosuppressant Switch Cuts Skin Cancer Post-Transplant
WEDNESDAY, July 25 (HealthDay News) -- In kidney-transplant patients with at least one cutaneous squamous-cell carcinoma, switching immunosuppressants (from calcineurin inhibitors to sirolimus) is associated with increased skin cancer-free survival and delayed development of new skin cancers, according to a study published in the July 26 issue of the New England Journal of Medicine.
Review Assesses Melanoma Burden From Use of Sunbeds
WEDNESDAY, July 25 (HealthDay News) -- Sunbed use correlates with a significantly increased risk of melanoma, with a dose-response association noted as well as an increased risk for those who first use sunbeds before age 35, according to a review published online July 24 in BMJ.
Components ID'd for Ideal Acne Severity Global Grading Tool
FRIDAY, July 20 (HealthDay News) -- Using an established method for consensus building, experts have identified the essential clinical components and features for an acne severity global grading tool, according to research published in the August issue of the Journal of the American Academy of Dermatology.
Most Doctors Satisfied With Electronic Health Records
THURSDAY, July 19 (HealthDay News) -- Although only 55 percent of physicians had adopted electronic health records (EHRs) in 2011, most are somewhat or very satisfied with their system and most report enhanced patient care, according to a July data brief issued by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS).
Chronic Periodontitis Increases Risk of Psoriasis
THURSDAY, July 19 (HealthDay News) -- Patients with chronic periodontitis (CP) are 1.5 times more likely to be diagnosed with psoriasis, and this risk is lessened but not nullified by CP treatment using gingivectomy or periodontal flap operation, according to research published online July 3 in the British Journal of Dermatology.
Poorer Patient Experience at Safety-Net Hospitals
THURSDAY, July 19 (HealthDay News) -- Safety-net hospitals (SNHs) perform worse on nearly every measure of patient experience, according to a study published online July 16 in the Archives of Internal Medicine.
Social Network Analysis IDs Informal Physician Networks
TUESDAY, July 17 (HealthDay News) -- Informal networks among physicians who share patients demonstrate substantial geographic variability, while within networks, physician and patient characteristics are similar, according to a study published in the July 18 issue of the Journal of the American Medical Association.
CO2 Laser Resurfacing Improves Atrophic Acne Scars
TUESDAY, July 17 (HealthDay News) -- The texture and atrophy of moderate-to-severe atrophic acne scars can be improved using ablative fractional carbon dioxide (CO2) laser resurfacing treatment once a month for three months, according to a study published in the August issue of Lasers in Surgery and Medicine.
Youth Access to Indoor Tanning Has Decreased Since 2003
MONDAY, July 16 (HealthDay News) -- Since 2003 there has been an increase in the number of countries with nationwide indoor tanning legislation restricting access for youth, according to a study published online July 16 in the Archives of Dermatology.
Hypertrophy Common in Older Patients With Port-Wine Stains
FRIDAY, July 13 (HealthDay News) -- Hypertrophy is present in the majority of patients with port-wine stains (PWS) who are over the age of 50 years, according to a study published online July 2 in the Journal of the American Academy of Dermatology.
Sentinel Lymph Node Biopsy Staging for Melanoma Reviewed
TUESDAY, July 10 (HealthDay News) -- For most patients with newly diagnosed melanoma, sentinel lymph node (SLN) biopsy is an acceptable method for lymph node staging, according to research published online July 9 in the Journal of Clinical Oncology.
Sunburn Detection and Repair Mechanism Identified
MONDAY, July 9 (HealthDay News) -- Sunburned skin is detected through release of damaged RNA, which stimulates an inflammatory response from the surrounding cells, according to research published online July 8 in Nature Medicine.
Sentinel Node Biopsy Safe for Vulvar Squamous Cell Cancer
FRIDAY, July 6 (HealthDay News) -- For women with squamous cell carcinoma (SCC) of the vulva, sentinel lymph node (SLN) biopsy may be safely used in place of inguinal femoral lymphadenectomy, according to research published online July 2 in the Journal of Clinical Oncology.
Correlates of Diabetic Foot Complications Identified
FRIDAY, July 6 (HealthDay News) -- For patients with diabetes, increased poly(ADP-ribose) (PAR) immunoreactivity, reduced abundance of type 1 procollagen, and impaired skin structure correlate with foot complications, according to a study published online June 29 in Diabetes Care.
Basal Cell Carcinoma Risk Down With Caffeine Intake
MONDAY, July 2 (HealthDay News) -- In both men and women, caffeine intake, from coffee and other sources, is inversely associated with the risk of basal cell carcinoma (BCC), according to research published in the July 1 issue of Cancer Research.
Direct Primary Closure Feasible for Lower Lip Reconstruction
MONDAY, July 2 (HealthDay News) -- Direct primary closure without undermining is a reliable method of reconstructing vermilionectomy defects of the lower lip, according to research published online June 18 in the British Journal of Dermatology.
Copyright © 2012 ScoutNews, LLC. All rights reserved.
|Previous: July 2012 Briefing - Cardiology||Next: July 2012 Briefing - Diabetes & Endocrinology|
Reader comments on this article are listed below. Review our comments policy.